ArticleClinical journal of gastroenterology2026
A case of recurrent early gastric cancer with a giant injection-related granuloma after endoscopic submucosal dissection resulting in non-curative resection.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 69-year-old man underwent endoscopic submucosal dissection (ESD) for early gastric cancer of the lower gastric body. The lateral margin was positive, corresponding to an eCura C-1 classification, and surveillance with upper gastrointestinal endoscopy every 6 months was performed. Local recurrence was detected 4 years later, and repeat ESD resulted in an eCura C-2 classification, prompting additional surgical resection. No lymph node metastasis was identified, and the patient remained recurrence-free for 11 months. Histopathological examination of the surgical specimen revealed extensive foreign body granuloma formation involving the deep muscularis propria and subserosal tissue. The granulomas were Alcian-blue positive, with staining intensity reduced after hyaluronidase treatment, suggesting the involvement of a hyaluronic acid-containing submucosal injection agent. No granulomas were observed in the repeat ESD specimen obtained 6 months before surgery. Inflammatory cell infiltration around the lymphatic vessels was observed, suggesting the involvement of lymphatic pathways to the gradual spread and extensive distribution of the granulomatous reaction over time. Submucosal injection-related granuloma formation after ESD is rare, but extensive granuloma formation may complicate the interpretation of post-ESD findings and potentially increase the technical difficulty of subsequent treatment. Clinicians should be aware of this possibility when performing surveillance and additional treatment after ESD.
Indexed as
Identifiers
42859371What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.